Search
Immatics NV
IMTXAdd to Watchlist
8.240USD
-0.360-4.19%
Market hours 09/24, 12:44（ET）
1.13BMarket Cap
LossP/E TTM
Immatics NV (IMTX) Stock Price Target & Forecast
Analyst Rating
Based on 10 analysts giving stock ratings to Immatics NV in the past month.
Strong Buy
5 Strong Buy
5 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
17.600USD+98.42%
IMTX Analyst Recommendation Trends
In the current month, IMTX has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IMTX average Analyst price target in the last month is 17.600.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
5
5
5
5
5
5
5
5
5
5
6
7
7
6
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
11
12
12
11
11
11
IMTX Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, IMTX EPS is projected to reach -0.540 in FY2026Q3, following reported EPS of -0.522 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q3
FY2026Q1
FY2026Q2
FY2025Q4
FY2026Q3
FY2026Q4
Forecast
--
-0.46
-0.49
-0.43
-0.54
-0.53
Actual
-0.35
-0.50
-0.52
--
--
--
Surprise
--
-7.79%
-6.91%
--
--
--
FAQs
What is Immatics NV's expected revenue for the next quarter?
Immatics NV's expected revenue is 12.40M.
What is Immatics NV's price target?
Analysts forecast that Immatics NV's price target is USD 17.60, with the highest forecast at USD 25.00 and the lowest forecast at USD 11.80.
How have Immatics NVIMTX's recent earnings per share performed?
The market expectation was USD -0.52, while Immatics NVIMTX's earnings per share (EPS) for the previous quarter was USD -0.50. EPS for the next quarter is expected at USD -0.54.
What is the analyst rating for Immatics NV?
Based on the ratings of Immatics NV's stock from 10 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.